Wilmington, Delaware, United States, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The bioabsorbable stents market stood at US$ 375.5 million in 2022. A CAGR of 6.4% is ...

The use of slow-release drugs in stents (drug-eluting stents) has dramatically reduced restenosis rates after percutaneous coronary intervention. However, these permanent metal devices may impair ...

Washington, DC - Predicting the future is a fool's game, and predicting successful drug and device therapy in cardiovascular medicine is just as tricky. When bioabsorbable stents emerged on the radar ...

A new study presented two-year data for the bioabsorbable everolimus coronary stent. An interventional cardiology specialist and official spokesperson for the European Society of Cardiology has ...

In 2012, more than 3 million people had stents inserted in their coronary arteries. These tiny mesh tubes prop open blood vessels healing from procedures like a balloon angioplasty, which widens ...

New York, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Bioabsorbable Stents Global Market Report 2021: COVID-19 Growth And ...

For about a decade, bioabsorbable stents were hailed as one of the most promising technologies in cardiology. Now, the future prospects of the technology are less than certain after a clinical trial ...

LONDON--(BUSINESS WIRE)--The bioabsorbable stents market is expected to grow by USD 5.68 billion during 2020-2024, according to Technavio. The report offers a detailed analysis of the impact of the ...

Barcelona, Spain and London, UK - Updates from bioabsorbable-stent trials suggest that investigators are making incremental improvements to devices that might one day be used for coronary ...

A study published today online in The Lancet (March 13, 2009) presented two year data for the bioabsorbable everolimus coronary stent. Commenting on the results, interventional cardiology specialist, ...